Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$4.80 USD
+0.01 (0.21%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $4.79 -0.01 (-0.21%) 5:54 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Verve Therapeutics (VERV) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.68 per share. This reflects a positive earnings surprise of 13.24%. Look out for VERV's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 2.78%.
Earnings History
Price & Consensus
Zacks News for VERV
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
VERV: What are Zacks experts saying now?
Zacks Private Portfolio Services